Pfizer Inc.

NYSE:PFE  
39.58
+0.38 (+0.98%)
4:03:58 PM EDT: $39.50 -0.08 (-0.19%)
Products, Strategic Combinations

Pyxis Oncology Announces Worldwide Licensing Agreement With Pfizer To Develop And Commercialize Multiple Antibody-Drug Conjugates

Published: 03/18/2021 13:03 GMT
Pfizer Inc. (PFE) - Pyxis Oncology Announces Worldwide Licensing Agreement With Pfizer to Develop and Commercialize Multiple Antibody-drug Conjugates.
Pyxis Oncolgy - Pfizer to Provide Co With a Worldwide, Royalty-bearing License to Develop and Commercialize Two Adc Candidates, Pyx-201 and Pyx-203.
Pyxis Oncology - Pfizer Will Receive an Upfront Payment and Equity in Pyxis.
Pyxis Oncology - Pfizer is Eligible to Receive Development and Sales-based Milestone Payments and Tiered Royalties on Potential Sales.